Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population

被引：0
|
作者：
Stephen J. Freedland
Matthew Davis
Andrew J. Epstein
Bhakti Arondekar
Jasmina I. Ivanova
机构：
[1] Cedars-Sinai Medical Center,Department of Urology
[2] Durham VA Medical Center,Urology Section
[3] Medicus Economics,undefined
[4] LLC,undefined
[5] Pfizer Inc.,undefined
[6] Pfizer Inc.,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2024年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 333
页数：6
相关论文
共 50 条
  • [1] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [2] Real-world treatment patterns among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population.
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 406 - 406
  • [3] Overall survival by race and ethnicity among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 144 - 144
  • [4] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [5] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [6] Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer
    Gupta, Shilpa
    To, Tu My
    Graf, Ryon
    Kadel, Edward E.
    Reilly, Norelle
    Albarmawi, Husam
    JCO PRECISION ONCOLOGY, 2024, 8
  • [7] Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
    Shore, Neal D.
    Laliberte, Francois
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise H.
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    ADVANCES IN THERAPY, 2021, 38 (08) : 4520 - 4540
  • [8] Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
    Neal D. Shore
    François Laliberté
    Raluca Ionescu-Ittu
    Lingfeng Yang
    Malena Mahendran
    Dominique Lejeune
    Louise H. Yu
    Joseph Burgents
    Mei Sheng Duh
    Sameer R. Ghate
    Advances in Therapy, 2021, 38 : 4520 - 4540
  • [9] Health care costs among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population.
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 10 - 10
  • [10] Treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC): A systematic literature review of 35 real-world observational studies.
    Raval, Amit D.
    Queen, V. Viji
    Korn, Matthew J.
    Quintero, Vanessa
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345